108 related articles for article (PubMed ID: 1851518)
1. [Immunohistochemical studies on epidermal growth factor receptor in hepatocellular carcinoma].
Tanaka H
Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):138-44. PubMed ID: 1851518
[TBL] [Abstract][Full Text] [Related]
2. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
Harada K; Shiota G; Kawasaki H
Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma.
Kira S; Nakanishi T; Suemori S; Kitamoto M; Watanabe Y; Kajiyama G
Liver; 1997 Aug; 17(4):177-82. PubMed ID: 9298487
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma.
Nikolova D; Chalovska V; Ivanova MG; Nikolovska E; Volkanovska A; Orovchanec N; Kunovska SK; Petrushevska G; Janevska V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Dec; 39(2-3):21-28. PubMed ID: 30864368
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and ultrastructural localization of epidermal growth factor receptor in human liver and hepatocellular carcinoma tissues.
Fukusato T; Mori S; Kawamoto T; Taniguchi S; Machinami R
Acta Pathol Jpn; 1990 Jan; 40(1):22-9. PubMed ID: 2156402
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].
Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM
Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908
[TBL] [Abstract][Full Text] [Related]
8. Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas.
Su YH; Ng KF; Yu MC; Wu TJ; Yeh TS; Lee WC; Lin YS; Hsieh TH; Lin CY; Yeh CT; Chen TC
J Gastroenterol Hepatol; 2015 Sep; 30(9):1397-404. PubMed ID: 25765471
[TBL] [Abstract][Full Text] [Related]
9. EGFR is phosphorylated at Ty845 in hepatocellular carcinoma.
Kannangai R; Sahin F; Torbenson MS
Mod Pathol; 2006 Nov; 19(11):1456-61. PubMed ID: 16936701
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between EGFR and p53 in hepatocellular carcinoma.
Cioca A; Cimpean A; Ceausu R; Fit AM; Zaharie T; Al-Hajjar N; Puia V; Raica M
Asian Pac J Cancer Prev; 2014; 15(19):8069-73. PubMed ID: 25338986
[TBL] [Abstract][Full Text] [Related]
11. Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma.
Yamaguchi K; Carr BI; Nalesnik MA
J Surg Oncol; 1995 Apr; 58(4):240-5. PubMed ID: 7723367
[TBL] [Abstract][Full Text] [Related]
12. GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.
Ye QH; Zhu WW; Zhang JB; Qin Y; Lu M; Lin GL; Guo L; Zhang B; Lin ZH; Roessler S; Forgues M; Jia HL; Lu L; Zhang XF; Lian BF; Xie L; Dong QZ; Tang ZY; Wang XW; Qin LX
Cancer Cell; 2016 Sep; 30(3):444-458. PubMed ID: 27569582
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of epidermal growth factor receptor and thymidylate synthase expression in primary liver cancer].
Guo FY; Yang J; Xiong SM; Zhu MQ; Gao S; Li JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):666-669. PubMed ID: 30481863
[No Abstract] [Full Text] [Related]
14. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
[TBL] [Abstract][Full Text] [Related]
15. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
16. B3GNT2, a polylactosamine synthase, regulates glycosylation of EGFR in H7721 human hepatocellular carcinoma cells.
Qiu H; Duan WM; Shu J; Cheng HX; Wang WP; Huang XE; Chen HL
Asian Pac J Cancer Prev; 2014; 15(24):10875-8. PubMed ID: 25605193
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.
Felipe-Silva A; Wakamatsu A; Dos Santos Cirqueira C; Alves VA
World J Gastroenterol; 2016 Jul; 22(27):6246-56. PubMed ID: 27468214
[TBL] [Abstract][Full Text] [Related]
18. C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.
Huan H; Wen X; Chen X; Wu L; Liu W; Habib NA; Bie P; Xia F
PLoS One; 2016; 11(4):e0153117. PubMed ID: 27050434
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma.
Buckley AF; Burgart LJ; Sahai V; Kakar S
Am J Clin Pathol; 2008 Feb; 129(2):245-51. PubMed ID: 18208805
[TBL] [Abstract][Full Text] [Related]
20. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.
Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L
J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
